Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

HBT Labs develops complex injectable medicines. We are a specialty pharmaceutical company focused on high barrier, parenteral generic drugs with complex chemistry and manufacturing processes. Our pipeline of drugs includes generic and 505(b)(2) products that target various treatment indications including cancer and CNS disorders. HBT has developed proprietary processes and technologies to produce complex drugs across multiple ...
HBT Labs develops complex injectable medicines. We are a specialty pharmaceutical company focused on high barrier, parenteral generic drugs with complex chemistry and manufacturing processes. Our pipeline of drugs includes generic and 505(b)(2) products that target various treatment indications including cancer and CNS disorders. HBT has developed proprietary processes and technologies to produce complex drugs across multiple delivery platforms, including liposomes, nanoparticles, emulsions, and long-acting injectable suspensions. HBT’s goal is to provide lower-cost treatment options to patients worldwide.

List your booth number for exhibitions, ask us